Cardiff Oncology

$8.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.44 (-4.89%) Today
+$0.02 (+0.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRDF and other stocks, options, and ETFs commission-free!

About CRDF

Cardiff Oncology, Inc. Common Stock, also called Cardiff Oncology, is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer.

CEO
Mark Erlander
Employees
12
Headquarters
San Diego, California
Founded
1999
Market Cap
333.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
771.86K
High Today
$9.19
Low Today
$8.51
Open Price
$8.93
Volume
890.63K
52 Week High
$25.50
52 Week Low
$0.825

CRDF Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

IRTC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure